BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33677100)

  • 1. Drugs for Prevention and Treatment of Aortic Stenosis: How Close Are We?
    Afshar M; Yazdan-Ashoori S; Engert JC; Thanassoulis G
    Can J Cardiol; 2021 Jul; 37(7):1016-1026. PubMed ID: 33677100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The re-emergence of lipoprotein(a) in a broader clinical arena.
    Tsimikas S
    Prog Cardiovasc Dis; 2016; 59(2):135-144. PubMed ID: 27497506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid theory in the pathogenesis of calcific aortic stenosis.
    Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention.
    Parolari A; Loardi C; Mussoni L; Cavallotti L; Camera M; Biglioli P; Tremoli E; Alamanni F
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):493-504. PubMed ID: 19162497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of calcific aortic stenosis by statins: myth or reality?].
    Peltier M; Tribouilloy C
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):818-22. PubMed ID: 17067101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcific aortic stenosis: same old story?
    Cowell SJ; Newby DE; Boon NA; Elder AT
    Age Ageing; 2004 Nov; 33(6):538-44. PubMed ID: 15308457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitor (statin) and aortic valve calcium.
    Shavelle DM; Takasu J; Budoff MJ; Mao S; Zhao XQ; O'Brien KD
    Lancet; 2002 Mar; 359(9312):1125-6. PubMed ID: 11943265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin treatment of patients with calcific aortic valve disease modulates extracellular adenosine metabolism on the cell surface of the aortic valve.
    Kutryb-Zajac B; Jablonska P; Hebanowska A; Lango R; Rogowski J; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1389-1399. PubMed ID: 32126886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy of calcific aortic stenosis: hype or hope?
    Liebe V; Brueckmann M; Borggrefe M; Kaden JJ
    Eur Heart J; 2006 Apr; 27(7):773-8. PubMed ID: 16399777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy for calcific aortic stenosis.
    Salas MJ; Santana O; Escolar E; Lamas GA
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):133-8. PubMed ID: 21828284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valvular disease: Cadherin 11 in calcific aortic valve disease.
    Huynh K
    Nat Rev Cardiol; 2017 Aug; 14(8):442. PubMed ID: 28660896
    [No Abstract]   [Full Text] [Related]  

  • 12. Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.
    Kleinauskienė R; Jonkaitienė R
    Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcific aortic stenosis: another face of atherosclerosis?
    Novaro GM; Griffin BP
    Cleve Clin J Med; 2003 May; 70(5):471-7. PubMed ID: 12779138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside.
    Hermans H; Herijgers P; Holvoet P; Verbeken E; Meuris B; Flameng W; Herregods MC
    Curr Probl Cardiol; 2010 Jun; 35(6):284-306. PubMed ID: 20451759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease.
    Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK
    Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.
    Tsimikas S
    Circ Res; 2019 Feb; 124(3):405-415. PubMed ID: 30702993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.
    Driscoll K; Cruz AD; Butcher JT
    Circ Res; 2021 Apr; 128(9):1344-1370. PubMed ID: 33914601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives.
    Pedriali G; Morciano G; Patergnani S; Cimaglia P; Morelli C; Mikus E; Ferrari R; Gasbarro V; Giorgi C; Wieckowski MR; Pinton P
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on pharmacotherapy of calcific aortic valve disease].
    DU M; Ma G; Shi Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):432-438. PubMed ID: 27868419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of calcific aortic valve stenosis].
    Kaden JJ
    Herz; 2006 Oct; 31(7):620-8. PubMed ID: 17072774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.